Learn About Osteosclerosis Autosomal Dominant
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
University Medical Diagnostic Associates Inc
Michael Econs is an Endocrinologist in Indianapolis, Indiana. Dr. Econs and is rated as an Elite provider by MediFind in the treatment of Osteosclerosis Autosomal Dominant. His top areas of expertise are Osteosclerosis Autosomal Dominant, Osteopetrosis, X-Linked Hypophosphatemia, and Hypophosphatemia.
Center For Pediatric Blood And Marrow Transplantation - Pediatric Specialty Care Journey Clinic
Paul Orchard is a Pediatric Hematologist Oncology specialist and a Pediatrics provider in Minneapolis, MN. Dr. Orchard and is rated as a Distinguished provider by MediFind in the treatment of Osteosclerosis Autosomal Dominant. His top areas of expertise are Adrenoleukodystrophy (ALD), Mucopolysaccharidosis Type 1 (MPS I, Hurler Syndrome), Mucopolysaccharidoses (MPS), Bone Marrow Transplant, and Osteotomy.
Anna Teti practices in L'aquila, Italy. Teti and is rated as an Elite expert by MediFind in the treatment of Osteosclerosis Autosomal Dominant. Her top areas of expertise are Osteosclerosis Autosomal Dominant, Osteopetrosis, Osteoporosis, Diastrophic Dysplasia, and Oophorectomy.
Summary: The purpose of this study is to understand the course of rare genetic disorders that affect the brain. This data is being analyzed to gain a better understanding of the progression of the rare neurodegenerative disorders and the effects of interventions.
Summary: This single-institution, phase II study is designed to test the ability to achieve donor hematopoietic engraftment while maintaining low rates of transplant-related mortality (TRM) using busulfan- and fludarabine-based conditioning regimens with busulfan therapeutic drug monitoring (TDM) for patients with various inherited metabolic disorders (IMD) and severe osteopetrosis (OP).